Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 7, Number 7—June 2001
THEME ISSUE
International Conference on Emerging Infectious Diseases 2000
Conference Presentations

Antibacterial Household Products: Cause for Concern

Stuart B. LevyComments to Author 
Author affiliation: Tufts University School of Medicine, Boston, Massachusetts, USA

Main Article

Table 6

Antibiotic susceptibility of methicillin-resistant Staphyloccocus aureus and benzalkonium chloride-resistant derivativesa

 MRSAb
Antibiotic Parent BZ-R-1 BZ-R-2
Oxacillin 16.0 512 512
Cloxacillin 0.5 256 512
Moxalactam 64.0 256 1024
Flomoxef 8.0 128 128
Cefmetazole 8.0 128 64
Cephalothin 64.0 128 128
Ampicillin 16.0 32 32
Chloramphenicol 4.0 4 4
Ofloxacin 8.0 32 32
Tetracycline 128.0 128 128
Benzalkonium chloride 5.0 10 10

aAdapted from (17).
bMIC (µg/ml) (BZ-R = parent resistant to benzalkonium chloride)

Main Article

References
  1. Neu  HC. The crisis in antibiotic resistance. Science. 1992;257:1064–73. DOIPubMed
  2. Levy  SB. The antibiotic paradox. How miracle drugs are destroying the miracle. New York: Plenum; 1992.
  3. McMurry  LM, Oethinger  M, Levy  SB. Triclosan targets lipid synthesis. Nature. 1998;394:531–2. DOIPubMed
  4. McMurry  LM, Oethinger  M, Levy  SB. Overexpression of marA, soxS or acrAB produces resistance to triclosan in Escherichia coli. FEMS Microbiol Lett. 1998;166:305–9. DOIPubMed
  5. Suller  MT, Russell  AD. Triclosan and antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother. 2000;46:11–8. DOIPubMed
  6. Hoang  TT, Schweizer  HP. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in homoserine lactone synthesis. J Bacteriol. 1999;181:5489–97.PubMed
  7. Russell  AD, Tattawasart  U, Maillard  J-Y, Furr  JR. Possible link between bacterial resistance and use of antibiotics and biocides. Antimicrob Agents Chemother. 1998;42:2151.PubMed
  8. Mereghetti  L, Quentin  R, Marquet-van der Mee  N, Audurier  A. Low sensitivity of Listeria monocytogenes to quaternary ammonium compounds. Appl Environ Microbiol. 2000;66:5083–6. DOIPubMed
  9. McMurry  LM, McDermott  PF, Levy  SB. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob Agents Chemother. 1999;43:711–3.PubMed
  10. Heath  RJ, Roch  CO. A triclosan-resistant bacterial enzyme. Nature. 2000;406:145–6. DOIPubMed
  11. Radosti-Slater  C, Aller  GV, DeWolf  W, Greenwood  R, Nicholas  R, Payne  D, Mode of action of triclosan in S. aureus [abstract]. American Society for Microbiology annual meeting, Los Angeles, California, 2000 May 21-24. Abstract 101, p. 26.
  12. Meade  MJ, Callahan  TM. Unique mechanism of triclosan resistance identified in environmental isolates [abstract]. American Society for Microbiology annual meeting, Los Angeles, California, 2000 May 21-24. Abstract 73, p. 19.
  13. Suzangar  S, Allison  DG, Gilbert  P. An evaluation of biocide-containing materials for their surface colonization-resistance and other properties [abstract] American Society for Microbiology annual meeting, Los Angeles, California, 2000 May 21-24. Abstract 53, p. 17.
  14. Alekshun  MN, Levy  SB. The mar regulon: multiple resistance to antibiotics and other toxic insults. Trends Microbiol. 1999;7:410–3. DOIPubMed
  15. Barbosa  T, Levy  SB. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol. 2000;182:3467–74. DOIPubMed
  16. Chuanchuen  R, Beinlich  K, Schweizer  HP. Multidrug efflux pumps and triclosan resistance in Pseudomonas aeruginosa [abstract]. American Society for Microbiology annual meeting, Los Angeles, California, 2000 May 21-24. Abstract 31, p. 8.
  17. Akimitsu  N, Hamamoto  H, Inoue  R, Shoji  M, Akamine  A, Takemori  K, Increase in resistance of methicillin-resistant Staphylococcus aureus to beta-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals. Antimicrob Agents Chemother. 1999;43:3042–3.PubMed
  18. Strachan  DP. Hay fever, hygiene, and household size. BMJ. 1989;299:1259–60. DOIPubMed
  19. Braun-Fahrländer  CH, Gassner  M, Grize  L, Neu  U, Sennhauser  FH, Varonier  HS, Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community. Clin Exp Allergy. 1999;29:28–34. DOIPubMed
  20. Rook  GAW, Stanford  JL. Give us this day our daily germs. Immunol Today. 1998;19:113–6.PubMed
  21. Matricardi  PM, Rosmini  F, Riondino  S, Fortini  M, Ferrigno  L, Rapicetta  M, Exposure to foodborne and orofecal microbes versus airbone viruses in relation to atopy and allergic asthma: epidemiological study. BMJ. 2000;320:412–7. DOIPubMed
  22. Aaby  P, Shaheen  SO, Heyes  CB, Goudiaby  A, Hall  AJ, Shiell  AW, Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy. 2000;30:644–50. DOIPubMed
  23. Folkerts  G, Walzl  G, Openshaw  PJM. Do common childhood infections "teach" the immune system not to be allergic? Immunol Today. 2000;21:118–20. DOIPubMed

Main Article

Page created: April 27, 2012
Page updated: April 27, 2012
Page reviewed: April 27, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external